
Vivalyx
Developer of Omnisol, an investigational perfusion solution for preserving donor organs
- Industry
- Biotech, MedTech
- Founded
- 2022
- Based in
- Germany
Verified revenue: not connected yet
Is Vivalyx yours? Claim this page and connect Stripe, the App Store or Google Play: your MRR and growth show here, read straight from the source.
About
Vivalyx develops Omnisol, a blood-replacing perfusion solution designed to preserve and revitalise donor organs for transplantation. Omnisol is investigational and has entered first-in-human clinical use. The company is based in Aachen, Germany and is backed by Armenia-based Granatus Ventures.
Team
- Andreas Schumacher, Co-founder and CEO (Founder)
- Benedict Doorschodt, Co-founder and CTO (Founder)
- René Tolba, Co-founder and CMO (Founder)
- Christian Bleilevens, Co-founder and CSO (Founder)
- Malte Brettel, Co-founder (Founder)
- Marius Rosenberg, Co-founder (Founder)
Audience
Followers on social networks
Profile data from Stanbase.